118 related articles for article (PubMed ID: 25120799)
1. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
Zhang C; Yao C; Li H; Wang G; He X
Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.
Lietz CE; Garbutt C; Barry WT; Deshpande V; Chen YL; Lozano-Calderon SA; Wang Y; Lawney B; Ebb D; Cote GM; Duan Z; Hornicek FJ; Choy E; Petur Nielsen G; Haibe-Kains B; Quackenbush J; Spentzos D
Sci Rep; 2020 Mar; 10(1):4409. PubMed ID: 32157112
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
Guo T; Wei R; Dean DC; Hornicek FJ; Duan Z
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34984436
[TBL] [Abstract][Full Text] [Related]
5. Retracted: MicroRNA-133b Inhibition Restores EGFR Expression and Accelerates Diabetes-Impaired Wound Healing.
Longevity OMAC
Oxid Med Cell Longev; 2024; 2024():9893472. PubMed ID: 38234561
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
Wang T; Ji F; Dai Z; Xie Y; Yuan D
Cancer Biomark; 2015; 15(5):543-50. PubMed ID: 26406942
[TBL] [Abstract][Full Text] [Related]
8. Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis.
Luo H; Wang P; Ye H; Shi J; Dai L; Wang X; Song C; Zhang J; Li J
Front Genet; 2020; 11():789. PubMed ID: 32849795
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.
Shi L; Xie C; Zhu J; Chen X
Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
13. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
Pang PC; Shi XY; Huang WL; Sun K
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
[TBL] [Abstract][Full Text] [Related]
14. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Diao ZB; Sun TX; Zong Y; Lin BC; Xia YS
J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712
[TBL] [Abstract][Full Text] [Related]
15. MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma.
Yang L; Li H; Huang A
Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073957
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-34a is a potential diagnostic and prognostic marker for osteosarcoma.
Wang T; Wu J; Liu X; Li S
Int J Clin Exp Pathol; 2017; 10(9):9683-9689. PubMed ID: 31966849
[TBL] [Abstract][Full Text] [Related]
17. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.
Gong L; Bao Q; Hu C; Wang J; Zhou Q; Wei L; Tong L; Zhang W; Shen Y
Biochem Biophys Res Commun; 2018 Jun; 500(2):170-176. PubMed ID: 29626470
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
20. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]